Cytokinligand til behandling af asthma og luftvejs-hyper-responsivitet

There is provided an antibody or antibody fragment which specifically binds to a portion of SEQ ID NO:2, wherein said portion consists of between 30 and 100 contiguous amino acids of SEQ ID NO:2, and wherein said portion contains amino acids selected from the group consisting of: (a) amino acid resi...

Full description

Saved in:
Bibliographic Details
Main Authors HAMMOND, ANGELA K, KUIJPER, JOSEPH L, GROSS, JANE A, SPRECHER, CINDY, A, DILLON, STACEY, R, DASOVICH, MARIA M, GRANT, FRANCIS, J, NOVAK, JULIA E
Format Patent
LanguageDanish
Published 08.11.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:There is provided an antibody or antibody fragment which specifically binds to a portion of SEQ ID NO:2, wherein said portion consists of between 30 and 100 contiguous amino acids of SEQ ID NO:2, and wherein said portion contains amino acids selected from the group consisting of: (a) amino acid residues 54 to 59 of SEQ ID NO: 2; (b) amino acid residues 129 to 134 of SEQ ID NO: 2; (c) amino acid residues 53 to 58 of SEQ ID NO: 2; (d) amino acid residues 35 to 40 of SEQ ID NO: 2; (e) amino acid residues 33 to 38 of SEQ ID NO: 2; (f) amino acid residues 114 to 119 of SEQ ID NO: 2; (g) amino acid residues 101 to 105 of SEQ ID NO: 2; (h) amino acid residues 126 to 131 of SEQ ID NO: 2; (i) amino acid residues 113 to 118 of SEQ ID NO: 2; and (j) amino acid residues 158 to 162 of SEQ ID NO:2.
Bibliography:Application Number: DK20080102636T